相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tapering Antipsychotic Treatment
Mark Abie Horowitz et al.
JAMA PSYCHIATRY (2021)
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
Hideaki Tani et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
One-stage dose-response meta-analysis for aggregated data
Alessio Crippa et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia
Hiroyoshi Takeuchi et al.
NEUROPSYCHOPHARMACOLOGY (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study
Zheng Tong et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method
Philipp H. Rothe et al.
SCHIZOPHRENIA RESEARCH (2018)
A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
Rajiv Tandon et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Dose Equivalents for Antipsychotic Drugs: The DDD Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2016)
Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2015)
Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study
W. Wolfgang Fleischhacker et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2014)
Equipercentile linking of the BPRS and the PANSS
S. Leucht et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Estimating Dopamine D2 Receptor Occupancy for Doses of 8 Antipsychotics A Meta-Analysis
Irene M. Lako et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Comparison of Treatment Response in Second-Episode Versus First-Episode Schizophrenia
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study
Hiroyoshi Takeuchi et al.
SCHIZOPHRENIA BULLETIN (2013)
Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study
Suresh Mallikaarjun et al.
SCHIZOPHRENIA RESEARCH (2013)
Interventions to reduce antipsychotic polypharmacy: A systematic review
Hideaki Tani et al.
SCHIZOPHRENIA RESEARCH (2013)
The evidence for illness progression after relapse in schizophrenia
Robin Emsley et al.
SCHIZOPHRENIA RESEARCH (2013)
Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia: A 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
John M. Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Stefan Leucht et al.
LANCET (2012)
Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
Robin Emsley et al.
SCHIZOPHRENIA RESEARCH (2012)
Dopamine D2 Receptor Occupancy and Clinical Effects A Systematic Review and Pooled Analysis
Hiroyuki Uchida et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Hiroyuki Uchida et al.
SCHIZOPHRENIA BULLETIN (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
John M. Kane et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Changes in Clinical Trials Methodology Over Time: A Systematic Review of Six Decades of Research in Psychopharmacology
Andre R. Brunoni et al.
PLOS ONE (2010)
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial
Eric Y. H. Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia
David Hough et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry
Jaime L. Peters et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia
Joseph P. McEvoy et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
A systematic review of mortality in schizophrenia - Is the differential mortality gap worsening over time?
Sukanta Saha et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: A placebo-controlled 26-week study
TA Pigott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study
M Arato et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia
JM Kane et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia
SJ Cooper et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
